Evidence map›Paper›PMID 38766092›Full record

ArticlemedRxiv : the preprint server for health sciences2024

Simultaneous co-circulation of two genotypes of dengue virus serotype 3 causing a large outbreak in Sri Lanka in year 2023.

Dinuka Ariyaratne, Bhagya Senadheera, Heshan Kuruppu, Tibutius Thanesh Pramanayagam Jayadas, Laksiri Gomes, Diyanath Ranasinghe, Farha Bary, Ananda Wijewickrama, Sully Márquez Aguilar, Shannon Bennett and 2 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Dinuka AriyaratneUniversity of Sri Jayewardenepura, Nugegoda, Sri Lanka.
Bhagya SenadheeraUniversity of Sri Jayewardenepura, Nugegoda, Sri Lanka.
Heshan KuruppuUniversity of Sri Jayewardenepura, Nugegoda, Sri Lanka.
Tibutius Thanesh Pramanayagam JayadasUniversity of Sri Jayewardenepura, Nugegoda, Sri Lanka.
Laksiri GomesUniversity of Sri Jayewardenepura, Nugegoda, Sri Lanka.
Diyanath RanasingheUniversity of Sri Jayewardenepura, Nugegoda, Sri Lanka.
Farha BaryUniversity of Sri Jayewardenepura, Nugegoda, Sri Lanka.
Ananda WijewickramaNational Institute of Infectious Diseases, Angoda, Sri Lanka.
Sully Márquez AguilarUniversidad San Francisco de Quito, Ecuador.
Shannon BennettUniversidad San Francisco de Quito, Ecuador.
Chandima JeewandaraUniversity of Sri Jayewardenepura, Nugegoda, Sri Lanka.
Gathsaurie Neelika MalavigeUniversity of Sri Jayewardenepura, Nugegoda, Sri Lanka.

Funding

American Asian Centers for Arbovirus Research and Enhanced Surveillance (A2CARES)U01AI151788 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI Josefina Coloma, Eva Harris · 2020 to 2026
$9.6M
NIAID NIH HHS U01 AI151788
6 · The paper itself

Abstract

As many other countries, Sri Lanka experienced a marked rise in the number of dengue cases in 2023, with an unusual pattern of disease epidemiology. This rise coincided with the emergence of dengue virus (DENV) serotype 3 in Sri Lanka as the predominant serotype after 2009. Interestingly, a discrepancy between NS1 rapid antigen test positivity and quantitative real time PCR positivity was observed, with 50% of NS1 positive samples being negative by molecular diagnostics. Following sequencing of the DENV-3 strains in 2023, we identified two DENV-3 genotypes (I and III) co-circulating. While DENV-3 genotype III was detected by the modified CDC DENV-3 primers, genotype I evaded detection due to key mutations at forward and reverse primer binding sites. The co-circulation of multiple genotypes associated with an increase in cases highlights the importance of continuous surveillance of DENVs to identify mutations resulting in non-detection by diagnostics and differences in virulence.

Indexed as

CDC PCR primersDenguegenotype Igenotype IIImolecular epidemiologymutationssequencingserotype 3

Identifiers

PMID38766092
PMCPMC11100923

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.